Climb Bio, Inc.
CLYM
$1.74
$0.106.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.82M | 4.10M | 5.69M | 4.95M | 5.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.89M | 10.68M | 23.02M | 10.91M | 11.73M |
| Operating Income | -14.89M | -10.68M | -23.02M | -10.91M | -11.73M |
| Income Before Tax | -12.89M | -8.67M | -20.78M | -8.42M | -8.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.89M | -8.67M | -20.78M | -8.42M | -8.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.89M | -8.67M | -20.78M | -8.42M | -8.90M |
| EBIT | -14.89M | -10.68M | -23.02M | -10.91M | -11.73M |
| EBITDA | -14.86M | -10.66M | -- | -- | -- |
| EPS Basic | -0.19 | -0.13 | -0.31 | -0.13 | -0.13 |
| Normalized Basic EPS | -0.12 | -0.08 | -0.20 | -0.09 | -0.08 |
| EPS Diluted | -0.19 | -0.13 | -0.31 | -0.13 | -0.13 |
| Normalized Diluted EPS | -0.12 | -0.08 | -0.20 | -0.09 | -0.08 |
| Average Basic Shares Outstanding | 68.00M | 67.59M | 67.46M | 64.74M | 67.01M |
| Average Diluted Shares Outstanding | 68.00M | 67.59M | 67.46M | 64.74M | 67.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |